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Abstract We have isolated cDNA clones corresponding to a 
new member of the murine tissue inhibitor of metalloproteinase 
(TIMP) family, designated Timp-4. The nucleotide sequence 
predicts a protein of 22 609 Da that contains the characteristic 12 
cysteine TIMP signature. TIMP-4 is more closely related to 
TIMP-2 and TIMP-3 than to TIMP-1 (48%, 45% and 38% 
identity, respectively). Analysis of Timp-4 mRNA expression in 
adult mouse tissues indicated a 1.2 kb transcript in brain, heart, 
ovary and skeletal muscle. This pattern of expression distin-
guishes Timp-4 from other Timps, suggesting that the TIMP-4 
protein may be an important tissue-specific regulator of 
extracellular matrix remodelling. 
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1. Introduction 
Tissue inhibitors of metalloproteinases (TIMP) are a family 
of secreted proteins whose primary recognized function is the 
ability to inhibit the active forms of matrix metalloproteinases 
(MMP) [1,2]. Since M M P s are recognized as the principal 
class of enzymes involved in extracellular matrix (ECM) deg-
radation, T IMPs provide critical control of the rate of E C M 
metabolism during normal tissue remodelling [3,4]. Thus proc-
esses such as wound healing [5], ovulation [6,7], embryo im-
plantation [8-11] and mammary gland involution [12,13] are 
characterized by orchestrated changes in the production of 
M M P s and TIMPs, supporting the notion that the local bal-
ance between the activities of M M P s and T IMPs is pivotal in 
determining the rate of E C M turnover. Disruption of this 
balance has been implicated in the pathological tissue damage 
seen in a number of disease states including tumour invasion 
and metastasis [14,15], cardiovascular disease [16] and multi-
ple sclerosis [17]. 
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Abbreviations: TIMP-4 designates protein; Timp-4 and TIMP4 are 
symbols for the mouse and human genes, respectively. 
The sequences of the mouse Timp-4 and human TIMP-4 genes 
described here have been submitted to GenBank. 
Given the importance of the T I M P proteins during E C M 
remodelling, we under took a degenerate oligonucleotide clon-
ing strategy to search for novel members of the Timp gene 
family. Isolated R N A from several murine tissues, including 
embryo, decidua, placenta, and heart were analysed by reverse 
transcription-polymerase chain reaction (RT-PCR) for the 
presence of new Timp-like cDNAs . We present here the iden-
tification of a new member of the murine Timp family, which 
has been designated Timp-4. 
2. Materials and methods 
2.1. RNA isolation 
Tissues to be used for RNA extraction were collected from 12-
week-old female CD1 mice (for testes RNA one 9-month-old male 
CD1 mouse was used), frozen on dry ice, and stored at —70°C until 
processed. Frozen tissue was homogenized and RNA prepared as 
previously described [18]. 
2.2. Design of degenerate oligonucleotides for PCR 
Degenerate primers were designed based on the VIRAK and (H/ 
E)CLW(T/M)D motifs found in TIMP-1, -2 and -3 from all animals 
for which the corresponding genes have been cloned [19]. The oligo-





Degenerate positions are indicated by square brackets. In addition to 
flanking nucleotides the 5'- and 3'-primers contained sequences for 
BamHl and Hindlll restriction enzyme sites, respectively (shown in 
bold) to facilitate cloning. These oligonucleotides were predicted to 
generate 77m/>-specific cDNA fragments of approximately 450 bp. 
2.3. Isolation of murine Timp-4 cDNAs 
For RT-PCR, 1 μg of RNA from either day-6.5 embryo with de-
cidua, day-8.5 embryo with decidua, day-11.5 embryo, day-11.5 pla-
centa, day-13 embryo, day-13 placenta, or adult heart was reverse 
transcribed using Superscript RT (Gibco-BRL) according to manufac-
turer's instructions. One-tenth of the RT product was used for PCR 
with the degenerate TIMP oligonucleotide primers. Forty cycles of 
PCR, each consisting of 1 min at 94°C, 2 min at 45°C, and 2 min 
at 72°C were performed using Taq polymerase (Pharmacia) in a 
Techne PHC-2 thermal cycler. PCR products of approximately 450 
bp were digested with BamHl and Hindlll, isolated from an agarose 
gel, and subcloned into pBluescript KS— (Stratagene) using standard 
procedures [20]. Following transformation, bacteria were grow on LB 
agar containing 50 μg/ml ampicillin and colonies were transferred to 
nylon filters (Hybond N, Amersham). Filters were hybridized with a 
mixture of [32P]dCTP-labelled Timp-1, Timp-2, and Timp-3 cDNA 
probes [19,21,22] and washed as previously described [19]. Dried filters 
were exposed to XAR5 X-ray film (Eastman Kodak). Filters were 
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then hybridized with [32P]dCTP-labelled first-strand cDNA (prepared 
as described above), washed and exposed to X-ray film. Colonies 
hybridizing only to the cDNA and not to Timp-l, -2, and -3 were 
grown in liquid culture and plasmid DNA isolated [19]. One clone 
(subsequently designated pBSmTIMP-4) chosen for automated se-
quence analysis (University Core DNA Sequencing Service, University 
of Calgary) contained a cDNA insert related to, but distinct from, 
Timp-l,-2 and -3. This cDNA was labelled with [32P]dCTP and used 
to screen a lambda ZAP murine heart cDNA library (Stratagene) 
according to manufacturer's instructions. Two identical clones con-
tained 5'-sequence information not included in the original PCR frag-
ment. A mouse brain cDNA library in lambda gtl 1 (generated from 
18-day-old mice at the Molecular Biology core of the Mental Retar-
dation Research Center at the University of California, Los Angeles, 
and provided by Dr. Wendy Macklin, Cleveland Clinic Foundation) 
was used for isolation of the 3'-end of the mouse Timp-4 cDNA. An 
aliquot of the library was boiled in distilled water and used as a 
template for PCR using a forward primer derived from the sequence 
of pBSmTIMP-4 (5'-AGCCTGAATCATCACTACC) together with 
lambda gtl l flanking primers. An 850 bp cDNA was cloned into 
pGEM-T (Promega) by T/A cloning and automated sequence analysis 
carried out (Molecular Biotechnology Core Facility of the Cleveland 
Clinic Foundation). Both strands of all cDNAs were sequenced, and 
DNA or protein sequences were generated using GCG software (Ge-
netics Computer Group). 
2.4. Isolation of human TIMP-4 
The cDNA insert from pBSmTIMP-4 was used to screen a lambda 
gtl l human placenta cDNA library (Clontech) and one positive clone 
was obtained. The insert of this phage could not be excised with 
EcoRl, therefore PCR with lambda gtl l flanking primers was used 
to amplify the insert. The PCR product of approximately 1.2 kbp was 
cloned into pGEM-T. Automated sequence analysis with vector and 
internal primers was carried out (Molecular Biotechnology Core Fa-
cility of the Cleveland Clinic Foundation). 
2.5. Protein sequence analysis 
Protein sequence analysis was performed by use of the Wisconsin 
Sequence Analysis Package (Version 8, Genetics Computer Group). 
Comparison of the deduced amino acid sequence of mouse TIMP-4 
with other TIMP sequences was performed using the Pattern-Induced 
Multisequence Alignment (PIMA) algorithm [23,24] which employs 
secondary structure-dependent gap penalties for comparative protein 
modelling. 
2.6. Northern blot analysis 
RNA was collected as described above. For ovaries and uterus, 
tissue from three animals was pooled to minimize effects of female 
cycling. Ten micrograms of total RNA from each tissue was electro-
phoresed on 1.1% agarose gels containing 2.2 M formaldehyde and 
transferred to nylon membranes (Amersham) as previously described 
[19]. Replicate filters were hybridized with 32P-labelled Timp-l, -2, -3 
and -4 cDNA probes followed by 18S ribosomal RNA cDNA to 
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TGCTGTGGCCCCCTGGACGGGGTGAGGCGTGCAGCTGTGCGCCTGCGCACCCCCAGCAGC 
L W P P G R G E A C S C A P A H P Q Q H 
ACTTCTGCCACTCGGCTCTAGTGATACGGGCCAAAATATCCAGTGAGAAAGTAGTCCCTG 
F C H S A L V I R A K I S S E K V V P A 
CCAGCAAAGACCCTGCTGACÄCTCAAAAACTGATCCGGTATGAAATCAAACAGATAAAGA 
S K D P A D T Q K L I R Y E I K Q I K M 
TGTTTAAAGGGTTCGAGAAGGCCAAGGATATTCAGTATGTCTACACGCCATTTGACTCTT 
F K G F E K A K D I Q Y V Y T P F D S S 
CCCTCTGTGGTGTGAAGCTAGAAACCAACAGTCACAAGCAGTATCTTTTGACTGGCCAGA 
L C G V K L E T N S H K Q . Y L L T G Q I 
TTCTCAGTGATGGAAAAGTCTTCATCCATCTGTGCAACTACATTGAGCCCTGGGAGGACC 
L S D G K V F I H L C N Y I E P W E D L 
TGTCCTTGGTGCAGAGGGAGAGCCTGAATCATCACTACCACCAGAACTGTGGCTGCCAAA 
S L V Q R E S L N H H Y H Q N C G C Q I 
TCACCACTTGCTATGCAGTGCCATGTACCATCTCAGCCCCCAATGAGTGTCTCTGGACGG 
T T C Y A V P C T I S A P H E C L W T D 
ACTGGCTGCTGGAACGGAAGCTCTATGGGTACCAGGCCCAGCACTATGTCTGCATGAAGC 
W L L E R K L Y G Y Q A Q H Y V C M K H 
ATGTTGATGGCATCTGCAGCTGGTACCGAGGCCACCTACACCTCCGGAAGGAGTACGTTG 
V D G I C S W Y R G H L H L R K E Y V D 
ACATCATCCAGCCCTAGTAGGGACCAGGAACCACÄTCCTTGGAAGCATTCTGAAGACCAA 
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Mouse 201 VDGICSWYRGHLHLRKEYVDIIQP* 225 
MM II I M I I I M IMM 
Human 158 VDGTCSWYRGHLPLRKEFVDIVQP* 182 
Fig. 1. A: DNA and predicted amino acid sequences of murine 
TIMP-4. The schematic underneath the sequence shows the origins 
of the three cDNA clones used to compile the composite Timp-4 se-
quence. B: Comparison of mouse and human TIMP-4 sequences. 
3.1. Cloning and characterization of mouse Timp-4 cDNAs 
A degenerate oligonucleotide-PCR strategy was used to 
identify a novel murine Timp c D N A . Degenerate primers 
were devised based on two short sequence motifs that are 
well-conserved in all of the known TIMPs from diverse spe-
cies, namely the V I R A K sequence close to the N-terminus of 
mature T I M P proteins (5'-primer) and the consensus (H/ 
E)CLW(T/M)D amino acid sequence (3'-primer) that lies in 
the C-terminal domain [19]. The primers were used for R T -
P C R with R N A isolated from murine embryos, decidua, pla-
centa and adult heart. Only heart R N A yielded a c D N A that 
was similar to, but distinct from, TimpA, -2 and -3 . Over-
lapping clones isolated from mouse heart and brain c D N A 
libraries plus the original P C R product were subjected to se-
quence analysis and a composite c D N A and predicted amino 
acid sequence of mouse Timp-4 is presented in Fig. 1A. With-
in the 940 bp cDNA, sequence from nucleotides 1 through 310 
was obtained from the heart library c D N A clone, sequence 
from nucleotides 141 through 539 was obtained from the orig-
inal PCR product, and sequence from nuclotides 441-940 
was obtained from the brain library c D N A clone. The open 
reading frame within the c D N A sequence encodes a predicted 
protein of 225 amino acids which contains hallmarks of T I M P 
proteins including 12 precisely conserved cysteine residues, 
and the V I R A K and E C L W T D features. The sequence of 
the mouse TIMP-4 protein was compared with the predicted 
amino acid sequence of a partial human TIMP-4 c D N A clone 
that correponds to the region from serine-44 to the C-termi-
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Fig. 2. Comparison of predicted amino acid sequences of mouse TIMPs. The sequences used for comparison include TIMP-1 [21,28] (these se-
quences are identical and differ at nine positions from another mouse TIMP-1 sequence in [29]); TIMP-2 [30], chosen in preference to [22] as 
there are two differences (H and E at positions 12 and 195) in which the chosen mouse sequence shows a better match with human TIMP-2; 
TIMP-3 [19]. The shaded areas represent 75% identity. The arrow indicates the N-terminus of the mature protein after cleavage of the signal 
pep tide. 
nus of the mouse protein, revealing 91% identity and 96% 
similarity (Fig. IB). 
3.2. Protein sequence comparison 
The deduced amino acid sequence of mouse TIMP-4 in-
cludes a 29-residue signal peptide and a mature protein of 
195 amino acids. Assuming no post-translational modifica-
tions, the latter is predicted to be 22609 Da with a pi of 
7.73. There are no N-glycosylation motifs in the sequence. 
A comparison of the mouse TIMP-4 sequence with sequences 
for other members of the TIMP family within this species is 
presented in Fig. 2, where numbering of the amino acid resi-
dues begins with the first residue of the signal peptide. TIMP-
4 is more closely related to TIMP-2 and TIMP-3 than TIMP-
1, exhibiting 48%, 45% and 38% identity, and 66%, 63% and 
54% similarity, respectively. In this respect, in the region of 
residues 59-64 in TIMP-2 (where there is a NDIYGN insert) 
TIMP-4 also has an insert of KDPAD (residues 62-66) and 
like both TIMP-2 and TIMP-3, TIMP-4 has an extended 'tail' 
at the C-terminus. The signal peptide of mouse TIMP-4 is the 
longest of the four TIMPs (29 amino acids compared to 24, 26 
and 23 for TIMP-1, -2 and -3, respectively). The mature pro-
tein contains a particularly large number of histidines (12 
compared to 4-6 for the other three mouse TIMPs). It has 
a significantly higher isoleucine content than TIMP-1 and 
TIMP-3 (14 residues versus 7) and like TIMP-3 a relatively 
high tyrosine content. 
3.3. RNA expression analysis 
Expression profiles for Timp-l, -2, -3 and -4 mRNAs in 
adult mouse tissues were compared by Northern blot analysis 
which is presented in Fig. 3. As has been observed previously 
[25,26], TimpA mRNA was found predominantly in ovary 
and bone. Timp-2 mRNA was detected in many tissues exam-
ined, with high levels observed in lung, ovaries, brain, testes 
and heart. Abundant expression of Timp-3 mRNA was ob-
served in kidney, lung, heart, brain and ovary [19,27]. In con-
trast to the patterns seen with Timp-\, -2 and -3, expression of 
Timp-4 mRNA was restricted to brain, heart, ovaries, skeletal 
muscle and skin. In other studies, we failed to detect expres-
sion of Timp-4 by Northern blot analysis in normal or Ha-ras-
transformed C3H10T1/2 mouse fibroblasts, though the other 
three Timp genes showed characteristic cell line-specific and 
stimulus-responsive patterns of expression [19,21,22]. 
4. Discussion 
Due to its essential nature in the maintenance of tissue 
structure, the integrity of the ECM must be preserved in the 
adult animal. However, in many normal physiological proc-
esses remodelling of the ECM is required. During ovulation, 
endometrial cycling, mammary gland development, wound 
healing, and embryo implantation and development, the 
ECM is locally degraded to effect the changes required. The 
MMP family of enzymes, by virtue of their ability to degrade 
all of the major protein components of the ECM [1,3,4], are 
key factors in the modulation of the local matrix environment. 
As such, control over the activity of these enzymes is exerted 
at several levels, including gene expression, proenzyme activa-
tion, and by inhibition of active enzyme by TIMPs [1-4]. 
Until now the family of TIMP proteins contained three mem-
bers, TIMP-1, -2 and -3. In this report, we describe the iso-
lation of a cDNA encoding a new member of the TIMP 
family. The predicted amino acid seqence of this cDNA en-
codes a protein containing the 12 cysteine residues and the 
VIRAK sequence conserved in all TIMP proteins. By these 
criteria we designate the new protein murine TIMP-4. 
The amino acid sequence of mouse TIMP-4 has regions of 
similarity with all of the other known TIMP proteins. More-
over, a high degree of evolutionary conservation is evident 
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Fig. 3. Northern blot analysis of adult murine tissues with Timp-l, 
-2, -3 and -4 probes. Hybridization to 18S ribosomal RNA demon-
strates equivalent loading between samples. Transcript sizes were de-
termined relative to the migration of 28S and 18S ribosomal RNAs. 
lg int, large intestine; sk muscle, skeletal muscle. 
because the protein sequence predicted from a partial human 
TIMP-4 cDNA clone that spans more than 80% of the protein 
coding region showed 91% amino acid identity with the mur-
ine TIMP-4. TIMP-4 is most closely related to TIMP-2 and 
like this protein it has no N-glycosylation motifs in its pri-
mary sequence. At 22 609 Da the predicted mature TIMP-4 
product is the largest core protein of all the mouse TIMPs 
(compared to 20243 Da, 21 729 Da and 21 676 Da for TIMP-
1, -2 and -3, respectively). However, a striking feature of 
mouse TIMP-4 is that at five positions, previously considered 
to be conserved for all known TIMPs, the TIMP-4 sequence 
deviates. These five residues are invariant in 17 TIMP-1, -2 
and -3 sequences from various species in available databanks 
(data not shown). Most notable among these substitutions are 
two in the highly conserved N-terminus of the protein within 
the sequence AFCN(S,A)(D,E)(L,V,I)VIRAK where A and N 
(underlined) are substituted by H at positions 40 and 43 in 
TIMP-4 (Fig. 2). Other substitutions include G to N, S to A 
and A to V at positions 155, 172 and 196, respectively, in the 
mouse TIMP-4 sequence. These latter three differences are 
also found in the partial human TIMP-4 clone indicating 
that they may have functional significance. It will be interest-
ing to determine whether the histidines at positions 40 and 43 
are also present in TIMP-4 from different species. 
Another interesting substitution that may have implications 
for the mechanism of inhibition of MMPs by TIMPs occurs at 
position 45 in mouse and human TIMP-4, where A replaces 
D/E in all other TIMP sequences. The negatively charged 
amino acid at this position, which precedes several hydropho-
bic residues, was previously proposed to be suitably placed to 
interact with the zinc within MMPs and render them inactive 
upon binding of the hydrophobic amino acids to the S l ' -S2 ' -
S3' region of the enzymes [1]. We have not yet expressed the 
TIMP-4 protein and therefore we do not know whether this 
sequence will yield an active metalloproteinase inhibitor. If it 
does, a different mechanism of inhibition of MMPs by TIMP-
4, at least, would need to be invoked. There is further support 
for a review of the proposed mechanism since a recent site-
directed mutagenesis study established that a D to Y change 
at this position in mouse TIMP-1 did not impair the ability of 
the protein to inhibit MMPs [31]. 
The expression pattern of murine Timp-4 mRNA in adult 
mouse tissues is distinct from that of the other Timps. Abun-
dant Timp-4 mRNA was detected in adult brain, heart, ovary 
and skeletal muscle, possibly reflecting the highly structured 
nature of these tissues. Expression of all four Timp mRNAs 
was detected in ovary, a finding which implies the need for 
exquisite control of matrix remodelling in this tissue. Roles 
for TIMP-1 in the regression of the corpus luteum (CL) in the 
cycling mouse and for TIMP-3 in the maintenance of struc-
tural integrity of the CL in the pregnant mouse have been 
suggested [7]. In a rat pseudopregnant model, TIMP-3 again 
appears to be involved in the maintenance of the CL [6]. It 
will be interesting to define any role that the TIMP-4 protein 
may play in these systems or other hormonally regulated 
events such as the development and function of the mammary 
gland and the normal cycling of the uterus. Preliminary evi-
dence indicates that the Timp-4 mRNA is regulated during 
post-natal mouse mammary development (R.K., unpublished 
observation). A function for TIMP-4 in the physiology and/or 
pathology of the brain, heart and skeletal muscle must await 
further experimentation. It is important to note that by in situ 
hybridization and Northern blot analysis, Timp-4 mRNA 
could not be detected during mouse embryogenesis (K.J.L. 
and S.S.A., unpublished observation), perhaps explaining 
why the cDNA was not isolated from mouse embryo or pla-
cental RNA. 
In summary, we have isolated a cDNA encoding a new 
member of the TIMP family of proteins, murine TIMP-4. 
Although TIMP-4 shares some common features with the 
other TIMPs it is clearly distinct in both its amino acid se-
quence and expression profile in the mouse. 
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